Last updated: April 12, 2021
Sponsor: Indonesia University
Overall Status: Completed
Phase
N/A
Condition
N/ATreatment
N/AClinical Study ID
NCT04844710
KET-845/UN2.F1/ ETIK/PPM.2020
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Male or female patients over 18 years of age, COVID-19 confirmed by RT-PCR withmild-moderate symptoms
- Willing to participate in research.
- Willing to follow the research process to completion.
Exclusion
Exclusion Criteria:
- The patient has contraindications to acupuncture (medical emergencies, pregnancy,malignancy, blood clotting disorders and consumption of anti-coagulant drugs).
- Patients with myeloproliferative disorders.
- There is a tumor or infection in the area where the acupuncture point is inserted.
- Patients with a history of uncontrolled Diabetes Mellitus with random blood sugarlevels > 200 mg / dL
Study Design
Total Participants: 22
Study Start date:
September 01, 2020
Estimated Completion Date:
November 20, 2020
Connect with a study center
Medical Acupuncture Department FKUI-RSCM
Jakarta, 10430
IndonesiaSite Not Available

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.